Share on LinkedInShare on LinkedIn

ARTICLE · 13 APRIL 2022

3D Printing In Pharmaceutical Industry

Khurana & Khurana, Advocates and IP Attorneys
Explore more from Khurana & Khurana, Advocates and IP Attorneys

3D Printing In Pharmaceutical Industry: The technology and formulation developed to efficiently transport a pharmacologically active molecule in the body in order to achieve therapeutic efficacy...

IndiaIntellectual Property

3D Printing In Pharmaceutical Industry: The technology and formulation developed to efficiently transport a pharmacologically active molecule in the body in order to achieve therapeutic efficacy in a safe manner is referred to as drug delivery. Controlling the release profile, which changes the pharmacokinetics of a medicine, can increase the efficiency and safety of a pharmaceutical product. In the clinical setting, inter-species heterogeneity is a common stumbling block. Because of the significant risk of unfavorable side effects, personalized therapy and dosing is gaining popularity. When the bulk manufacture of medications focuses on the average population, the risk of adverse responses is higher in the pediatric and geriatric groups. Multiple active component dosage forms, where the formulation can be as a single mix or multi-layer printed tablets with sustained release qualities, can benefit from 3D printing. This reduces the frequency and number of dosage form

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from